Trial intelligence / Profile preview

Evaluation of antibiotic prophylaxis in operative hysteroscopy

2009-011775-78Phase 3Active

Sponsor
Università Campus Bio-Medico di Roma
Start
Apr 2009
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of cefazolin in surgical site infection (SSI) and Postoperative fever (POF), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Postoperative fever. Started Apr 2009; status: active.

02

Drugs

cefazolin
03

Conditions

surgical site infection (SSI)Postoperative fever (POF)

Beyond the preview

Go deeper on 2009-011775-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011775-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call